Towa Pharmaceutical Co., Ltd.'s (TSE:4553) earnings announcement last week didn't impress shareholders. Despite the soft profit numbers, our analysis has optimistic about the overall quality of the income statement.
Importantly, our data indicates that Towa Pharmaceutical's profit was reduced by JP¥14b, due to unusual items, over the last year. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's hardly a surprise given these line items are considered unusual. Towa Pharmaceutical took a rather significant hit from unusual items in the year to September 2026. All else being equal, this would likely have the effect of making the statutory profit look worse than its underlying earnings power.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
As we discussed above, we think the significant unusual expense will make Towa Pharmaceutical's statutory profit lower than it would otherwise have been. Based on this observation, we consider it possible that Towa Pharmaceutical's statutory profit actually understates its earnings potential! Unfortunately, though, its earnings per share actually fell back over the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. So while earnings quality is important, it's equally important to consider the risks facing Towa Pharmaceutical at this point in time. For instance, we've identified 4 warning signs for Towa Pharmaceutical (1 shouldn't be ignored) you should be familiar with.
Today we've zoomed in on a single data point to better understand the nature of Towa Pharmaceutical's profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.